Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR13A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,306
Award facts
- Contract value 100% obligated
- $14,306.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $14,306 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on January 23, 2026, for TYPHIM VI 25 MCG/0.5 ML syringes. The award, which is not set-aside, is expected to be completed by January 26, 2026, and will be performed at the company's Conshohocken facility. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., which also maintains the parent IDC with DLA through December 31, 2031. Both entities serve as critical vendors for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical supply chain utilizes these contracts to ensure consistent access to essential pharmaceutical commodities, vaccines, syringes, and medical supplies across multiple therapeutic domains for military treatment facilities and veteran healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FR13A?
SPE2DR26FR13A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FR13A worth?
The government has obligated $14,306 on SPE2DR26FR13A.
Is contract SPE2DR26FR13A an order under another contract?
Yes. SPE2DR26FR13A is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR13A competed?
The extent of competition for SPE2DR26FR13A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award